PillPotassium Chloride
Brands: Klor-Con · Potassium Chloride
20 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 36 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it20 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Aphena Pharma Solutions - Tennessee, LLC | unknown | 21 | SUPPLYING |
| A-S Medication Solutions | unknown | 20 | SUPPLYING |
| Upsher-Smith Laboratories, LLC | unknown | 14 | SUPPLYING |
| Slate Run Pharmaceuticals, LLC | unknown | 10 | SUPPLYING |
| Aurobindo Pharma Limited | unknown | 8 | SUPPLYING |
| Macleods Pharmaceuticals Limited | unknown | 8 | SUPPLYING |
| Advagen Pharma Ltd | unknown | 7 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 6 | SUPPLYING |
| Epic Pharma, LLC | unknown | 6 | SUPPLYING |
| NCS HealthCare of KY, LLC dba Vangard Labs | unknown | 5 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 3 | SUPPLYING |
| Northwind Health Company, LLC | unknown | 3 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | unknown | 3 | SUPPLYING |
| BluePoint Laboratories | unknown | 2 | SUPPLYING |
| PD-Rx Pharmaceuticals, Inc. | unknown | 2 | SUPPLYING |
+ 6 more labelers
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jul 23, 2025RESOLVEDShortage resolved: Potassium Chloride Tablet, Extended Release (Upsher-Smith Laboratories, LLC)
Potassium Chloride Tablet, Extended Release — reported in shortage by Upsher-Smith Laboratories, LLC. Therapeutic category: Endocrinology/Metabolism, Gastroenterology.
- Jul 23, 2025SHORTAGEDrug shortage: Potassium Chloride Tablet, Extended Release (Upsher-Smith Laboratories, LLC)
Potassium Chloride Tablet, Extended Release — reported in shortage by Upsher-Smith Laboratories, LLC. Therapeutic category: Endocrinology/Metabolism, Gastroenterology.
- Jan 30, 2025RECALLRecall (Class II): Potassium Chloride Extended-Release Tablets, USP, 10 mEq (750 mg), 100 Tablets per carton (10 x 10 unit dose blisters),…
Failed Dissolution Specifications. — Recalling firm: The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories — Nationwide in the USA